Literature DB >> 27400195

Interleukin (IL)-39 [IL-23p19/Epstein-Barr virus-induced 3 (Ebi3)] induces differentiation/expansion of neutrophils in lupus-prone mice.

X Wang1, X Liu2,3, Y Zhang2,4, Z Wang2,5, G Zhu2,6, G Han2, G Chen2, C Hou2, T Wang4, N Ma7, B Shen2, Y Li2, H Xiao8, R Wang2.   

Abstract

Interleukin (IL)-12 family cytokines play critical roles in autoimmune diseases. Our previous study has shown that IL-23p19 and Epstein-Barr virus-induced 3 (Ebi3) form a new IL-12 family heterodimer, IL-23p19/Ebi3, termed IL-39, and knock-down of p19 or Ebi3 reduced diseases by transferred GL7+ B cells in lupus-prone mice. In the present study, we explore further the possible effect of IL-39 on murine lupus. We found that IL-39 in vitro and in vivo induces differentiation and/or expansion of neutrophils. GL7+ B cells up-regulated neutrophils by secreting IL-39, whereas IL-39-deficient GL7+ B cells lost the capacity to up-regulate neutrophils in lupus-prone mice and homozygous CD19cre (CD19-deficient) mice. Finally, we found that IL-39-induced neutrophils had a positive feedback on IL-39 expression in activated B cells by secreting B cell activation factor (BAFF). Taken together, our results suggest that IL-39 induces differentiation and/or expansion of neutrophils in lupus-prone mice.
© 2016 British Society for Immunology.

Entities:  

Keywords:  BAFF; IL-39; autoimmune diseases; lupus; neutrophils

Mesh:

Substances:

Year:  2016        PMID: 27400195      PMCID: PMC5054574          DOI: 10.1111/cei.12840

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  49 in total

Review 1.  Neutrophils in the pathogenesis and manifestations of SLE.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

2.  Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice.

Authors:  Edward E S Nieuwenhuis; Markus F Neurath; Nadia Corazza; Hideki Iijima; Joanne Trgovcich; Stefan Wirtz; Jonathan Glickman; Dan Bailey; Masaru Yoshida; Peter R Galle; Mitchell Kronenberg; Mark Birkenbach; Richard S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

3.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.

Authors:  J A Gross; J Johnston; S Mudri; R Enselman; S R Dillon; K Madden; W Xu; J Parrish-Novak; D Foster; C Lofton-Day; M Moore; A Littau; A Grossman; H Haugen; K Foley; H Blumberg; K Harrison; W Kindsvogel; C H Clegg
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

Review 4.  Updating on the pathogenesis of systemic lupus erythematosus.

Authors:  R Gualtierotti; M Biggioggero; A E Penatti; P L Meroni
Journal:  Autoimmun Rev       Date:  2010-09-21       Impact factor: 9.754

Review 5.  The role of neutrophils in the pathogenesis of systemic lupus erythematosus.

Authors:  Carolyne K Smith; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2015-09       Impact factor: 5.006

Review 6.  BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus.

Authors:  Fabien B Vincent; Eric F Morand; Fabienne Mackay
Journal:  Immunol Cell Biol       Date:  2012-01-10       Impact factor: 5.126

Review 7.  Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.

Authors:  Lin Sun; Chang He; Lekha Nair; Justine Yeung; Charles E Egwuagu
Journal:  Cytokine       Date:  2015-03-18       Impact factor: 3.861

8.  Differential expression of GL7 activation antigen on bone marrow B cell subpopulations and peripheral B cells.

Authors:  L Cervenak; A Magyar; R Boja; G László
Journal:  Immunol Lett       Date:  2001-09-03       Impact factor: 3.685

9.  Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis.

Authors:  Takashi Igawa; Hitoshi Nakashima; Atsushi Sadanaga; Kohsuke Masutani; Katsuhisa Miyake; Sakiko Shimizu; Atsunobu Takeda; Shinjiro Hamano; Hiroki Yoshida
Journal:  Mod Rheumatol       Date:  2008-09-10       Impact factor: 3.023

10.  Interleukin-35 induces regulatory B cells that suppress autoimmune disease.

Authors:  Ren-Xi Wang; Cheng-Rong Yu; Ivy M Dambuza; Rashid M Mahdi; Monika B Dolinska; Yuri V Sergeev; Paul T Wingfield; Sung-Hye Kim; Charles E Egwuagu
Journal:  Nat Med       Date:  2014-04-17       Impact factor: 53.440

View more
  21 in total

1.  IL-39 acts as a friend to pancreatic cancer.

Authors:  Alicia A Manning; Lei Zhao; Ziwen Zhu; Huaping Xiao; Chase G Redington; Vivi A Ding; Theodore Stewart-Hester; Qian Bai; Jacob Dunlap; Mark R Wakefield; Yujiang Fang
Journal:  Med Oncol       Date:  2018-12-01       Impact factor: 3.064

Review 2.  Interleukin 30 to Interleukin 40.

Authors:  Jovani Catalan-Dibene; Laura L McIntyre; Albert Zlotnik
Journal:  J Interferon Cytokine Res       Date:  2018-10       Impact factor: 2.607

3.  Meteorin-like/Meteorin-β Is a Novel Immunoregulatory Cytokine Associated with Inflammation.

Authors:  Irina Ushach; Gerardo Arrevillaga-Boni; Gina N Heller; Egest Pone; Marcela Hernandez-Ruiz; Jovani Catalan-Dibene; Peter Hevezi; Albert Zlotnik
Journal:  J Immunol       Date:  2018-11-21       Impact factor: 5.422

Review 4.  The Immunobiology of the Interleukin-12 Family: Room for Discovery.

Authors:  Elia D Tait Wojno; Christopher A Hunter; Jason S Stumhofer
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

5.  Evaluation of IL-23p19/Ebi3 (IL-39) gingival crevicular fluid levels in periodontal health, gingivitis, and periodontitis.

Authors:  Aysegul Sari; Serdar Dogan; Luigi Nibali; Serhat Koseoglu
Journal:  Clin Oral Investig       Date:  2022-08-20       Impact factor: 3.606

6.  High interleukin-18 and low FOXP3 mRNAs in peripheral blood of women with severe systemic lupus erythematosus: a cross-sectional study.

Authors:  Lyuba D Miteva; Irena M Manolova; Mariana G Ivanova; Rumen M Stoilov; Spaska A Stanilova
Journal:  Rheumatol Int       Date:  2020-03-09       Impact factor: 2.631

7.  EBV-induced gene 3 augments IL-23Rα protein expression through a chaperone calnexin.

Authors:  Izuru Mizoguchi; Mio Ohashi; Hideaki Hasegawa; Yukino Chiba; Naoko Orii; Shinya Inoue; Chiaki Kawana; Mingli Xu; Katsuko Sudo; Koji Fujita; Masahiko Kuroda; Shin-Ichi Hashimoto; Kouji Matsushima; Takayuki Yoshimoto
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

8.  Identification of IL-40, a Novel B Cell-Associated Cytokine.

Authors:  Jovani Catalan-Dibene; Monica I Vazquez; Van Phi Luu; Sean-Paul Nuccio; Alborz Karimzadeh; Jenna M Kastenschmidt; S Armando Villalta; Irina Ushach; Egest J Pone; Paolo Casali; Manuela Raffatellu; Amanda M Burkhardt; Marcela Hernandez-Ruiz; Gina Heller; Peter A Hevezi; Albert Zlotnik
Journal:  J Immunol       Date:  2017-10-04       Impact factor: 5.422

Review 9.  Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family.

Authors:  Hideaki Hasegawa; Izuru Mizoguchi; Yukino Chiba; Mio Ohashi; Mingli Xu; Takayuki Yoshimoto
Journal:  Front Immunol       Date:  2016-11-04       Impact factor: 7.561

10.  Anti‑IL‑39 (IL‑23p19/Ebi3) polyclonal antibodies ameliorate autoimmune symptoms in lupus‑like mice.

Authors:  Xiaoqian Wang; Yu Zhang; Zhiding Wang; Xiaoling Liu; Gaizhi Zhu; Gencheng Han; Guojiang Chen; Chunmei Hou; Tianxiao Wang; Beifen Shen; Yan Li; He Xiao; Ning Ma; Renxi Wang
Journal:  Mol Med Rep       Date:  2017-11-14       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.